Akèy › Amiloidoz Chèn Limyè Imunoglobulin
Etid klinik pou Amiloidoz Chèn Limyè Imunoglobulin ap rekrite nan Etazini
16 etid pou Amiloidoz Chèn Limyè Imunoglobulin ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA7 etid
- Rochester, MN5 etid
- Durham, NC4 etid
- New York City, NY4 etid
- Columbus, OH3 etid
- Cleveland, OH3 etid
Pa eta
- Arizona3 etid
- Florid3 etid
- Kalifòni3 etid
- Massachusetts7 etid
- Minnesota5 etid
- New York4 etid
- North Carolina4 etid
- Ohio5 etid
- Tennessee4 etid
- Texas3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05898646SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07850284A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06768489Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06569147Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05145816A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT05951816A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 17, 2026 · NCT07224672Teclistamab-Daratumumab in AL Amyloidosis
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Jul 13, 2026 · NCT07110844A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07081646Registry of Older Patients With Cancer
Ap rekriteEtid obsèvasyon
Laj 65 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT01137825Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06022939Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 23, 2026 · NCT01408225Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 1, 2025 · NCT00898235Molecular Imaging of Primary Amyloid Cardiomyopathy
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Nov 14, 2025 · NCT02641145Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Oct 27, 2025 · NCT01137643Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Tout sèks · Mizajou Aug 6, 2025 · NCT06365060Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.